RE; Options Trade Ideas from Benzinga In this market, there's never been a better time to profit with options. Get Benzinga Options: Starter Edition to follow Nic Chahine's high-conviction options trades. Click here to subscribe.
AIkido Pharma is a U.S.-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Aikido Pharma's stock was trading up 5.77% at 92 cents on Thursday during the time of publication. The stock has a 52-week high of $5.52 and a 52-week low of 48 cents.